We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Possible Treatment for Insomnia

By HospiMedica International staff writers
Posted on 23 Jun 2009
Insomniacs who were subjected to mild frontal cerebral hypothermia showed reduced brain metabolism in the frontal cortex and reported an overall better and more refreshing sleep.

Researchers at the University of Pittsburgh (PITT; PA, USA) screened 148 subjects and identified 12 that met diagnostic and statistical manual of mental disorders (DSM-IV) criteria for primary insomnia. More...
Eight of these completed the study. The patients used a medical device that overlay the frontal cortex on the scalp and delivered either a neutral temperature (control) or a mild hypothermic effect for 60 minutes; the subjects served as their own controls. The treatment was applied before bedtime and during the first cycle of non-rapid eye movement (NREM) sleep. The researchers analyzed core body temperature and NREM sleep using 18F-fluorodeoxyglucose positron-emission-tomography (PET) scanning.

The researchers found that the hypothermic treatment led to reduced metabolism in the underlying frontal and cingulate cortex. Five of eight patients experienced reduction in whole brain metabolism with the treatment. Treatment also led to an accelerated reduction in core body temperature at sleep onset. Of the patients, 75% reported sleep-related improvements, including a decrease in distracting thoughts, improved sleep maintenance, and more refreshing sleep. The findings were presented at the annual meeting of the associated professional sleep societies (SLEEP 2009), held during June 2009 in Seattle (WA, USA).

"It moves [insomnia] patients into a deeper sleep,” said lead author and study presenter Eric Nofzinger, M.D., a professor of psychiatry at PITT, who explained that the new approach is designed to counter the metabolic changes seen in brain images. "We're trying to push that back to the normal condition by applying surface cooling.”

Earlier brain-imaging studies have shown a reduction in metabolism in the frontal cortex in healthy individuals as they fell asleep. Insomniacs, however, experienced an increased metabolism compared with healthy volunteers, both before going to sleep and during NREM sleep. Other evidence suggests that people with insomnia have a generally higher metabolism, including faster heartbeats and hyper-arousal.

Related Links:

University of Pittsburgh



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.